PSQH exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across almost all health metrics. While the company shows impressive YoY revenue growth of 109% and strong gross margins (69.25%), these are completely offset by a catastrophic profit margin of -200.95% and a high Debt/Equity ratio of 2.63. The company consistently misses earnings estimates with a -78.27% average surprise over the last four quarters. Combined with bearish insider selling and a long-term price collapse, the stock remains a high-risk speculative asset.